Answers are grounded in this paper and cite their sources.
In 2020, BLOODPAC recommended 11 pre-analytical minimal technical data elements for collection and submission of liquid biopsy data to public databases. This article expands on that work by recommending 22 clinical context and 10 patient context data elements. These elements, essential for liquid biopsy data submitted to repositories like the BLOODPAC Data Commons, cover tumor characteristics, disease progression, and patient demographics, supporting biomarker validation, research, and clinical trials.
No takes yet. Share an insight, caveat, or question.
Grossman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: